홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Paclitaxel → Paclitaxel cephalomannine

HRID 1109266
인쇄

반응식

HRID 1109266 반응식
[CH3:1][C:2]1[C@@H:19]([O:20][C:21]([C@H:23]([OH:40])[C@@H:24]([NH:31][C:32]([C:34]2[CH:35]=[CH:36][CH:37]=[CH:38][CH:39]=2)=[O:33])[C:25]2[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=2)=[O:22])[CH2:18][C@:14]2([OH:41])[C:15]([CH3:17])([CH3:16])[C:3]=1[C@@H:4]([O:59][C:60]([CH3:62])=[O:61])[C:5]([C@@:7]1([CH3:58])[C@H:12]([C@@H:13]2[O:42][C:43]([C:45]2[CH:46]=[CH:47][CH:48]=[CH:49][CH:50]=2)=[O:44])[C@:11]2([O:53][C:54]([CH3:56])=[O:55])[CH2:51][O:52][C@@H:10]2[CH2:9][C@@H:8]1[OH:57])=[O:6].[CH3:63]/[CH:64]=[C:65](/[C:67]([NH:69][C@H:70]([C@@H:77]([OH:122])[C:78]([O:80][C@@H:81]1[C:102]([CH3:103])=[C:101]2[C:104]([CH3:106])([CH3:105])[C@:83]([OH:121])([C@@H:84]([O:112][C:113]([C:115]3[CH:116]=[CH:117][CH:118]=[CH:119][CH:120]=3)=[O:114])[C@@H:85]3[C@:90]4([O:93][C:94]([CH3:96])=[O:95])[CH2:91][O:92][C@@H:89]4[CH2:88][C@H:87]([OH:97])[C@@:86]3([CH3:111])[C:98]([C@@H:100]2[O:107][C:108]([CH3:110])=[O:109])=[O:99])[CH2:82]1)=[O:79])[C:71]1[CH:72]=[CH:73][CH:74]=[CH:75][CH:76]=1)=[O:68])\[CH3:66]>C(OCC)(=O)C.O=[Pt]=O>[CH3:1][C:2]1[C@@H:19]([O:20][C:21]([C@H:23]([OH:40])[C@@H:24]([NH:31][C:32]([C:34]2[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=2)=[O:33])[C:25]2[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=2)=[O:22])[CH2:18][C@:14]2([OH:41])[C:15]([CH3:16])([CH3:17])[C:3]=1[C@@H:4]([O:59][C:60]([CH3:62])=[O:61])[C:5]([C@@:7]1([CH3:58])[C@H:12]([C@@H:13]2[O:42][C:43]([C:45]2[CH:50]=[CH:49][CH:48]=[CH:47][CH:46]=2)=[O:44])[C@:11]2([O:53][C:54]([CH3:56])=[O:55])[CH2:51][O:52][C@@H:10]2[CH2:9][C@@H:8]1[OH:57])=[O:6].[CH3:63]/[CH:64]=[C:65](/[C:67]([NH:69][C@H:70]([C@@H:77]([OH:122])[C:78]([O:80][C@@H:81]1[C:102]([CH3:103])=[C:101]2[C:104]([CH3:105])([CH3:106])[C@:83]([OH:121])([C@@H:84]([O:112][C:113]([C:115]3[CH:116]=[CH:117][CH:118]=[CH:119][CH:120]=3)=[O:114])[C@@H:85]3[C@:90]4([O:93][C:94]([CH3:96])=[O:95])[CH2:91][O:92][C@@H:89]4[CH2:88][C@H:87]([OH:97])[C@@:86]3([CH3:111])[C:98]([C@@H:100]2[O:107][C:108]([CH3:110])=[O:109])=[O:99])[CH2:82]1)=[O:79])[C:71]1[CH:72]=[CH:73][CH:74]=[CH:75][CH:76]=1)=[O:68])\[CH3:66]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 36314PaclitaxelHCID 6436208Cephalomannine

생성물 1

HCID 86586153Paclitaxel cephalomannine

시약·촉매·용매 2

HCID 345198Adams' catalyst촉매HCID 8857
Ethyl Acetate
용매

실험 절차

A 262 mg quantity of an approximately 50/50 mixture of taxol and cephalomannine was dissolved in 10 mL of ethyl acetate in a 100 mL round bottom flask with magnetic stirring. Then 20 mg of PtO2 was added and the flask was attached to a hydrogenation apparatus. After flushing the flask five times with hydrogen gas, the solution was stirred at room temperature. After 1 hour, the flask was removed from the hydrogenation apparatus and the solution filtered through Celite to remove the catalyst. The resulting solution was evaporated to dryness under vacuum. The result was 262 mg (100%) of a mixture of taxol and dihydrocephalomannine. No further purification was performed and the sample was used as is in the next step.

후처리

  1. customAfter flushing the flask five times with hydrogen gas
  2. customthe flask was removed from the hydrogenation apparatus
  3. filtrationthe solution filtered through Celite
  4. customto remove the catalyst
  5. customThe resulting solution was evaporated to dryness under vacuum
  6. customNo further purification

출처 및 근거

ORD 기록
ord-a54f79637bfe4f938d92d89b1bc13c39
출처 데이터셋
uspto-grants-1994_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05319112

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트